Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)

Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Question reference: S6W-36374

Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
Date lodged: Monday, 07 April 2025
Current Status: Answered by Jenni Minto on 1 May 2025

To ask the Scottish Government what (a) review it (i) has undertaken and (ii) plans to undertake and (b) engagement it has had with the UK Government in light of reports that an estimated 30,000 women across the UK were prescribed stilbestrol, and how many women affected were resident in Scotland.

I have the utmost sympathy for the women who may have been adversely affected by diethylstilbestrol (otherwise known as DES or stilbestrol).

The regulations for the licensing, safety and efficacy of medicines is currently reserved to the UK Government and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA). Any review of diethylstilbestrol (otherwise known as DES or stilbestrol) would ultimately be a matter for them to consider.

Chamber and committees

Questions and answers

Filter your results Hide all filters

Question reference: S6W-36374

Answer